Global Cause
In this issue
-
We need new antibiotics, but that’s not all…
We need new medicines as well as a better understanding of why, how, and where resistance to antimicrobials develops.
-
Why is there such a focus on antibiotic resistance at the moment?
It is because many of these precious medicines have lost their effectiveness to treat the bacteria causing common infections such as pneumonia, skin and kidney infections, gonorrhoea, and tuberculosis.
-
Beating antibiotic resistance together
Antibiotics are medicine’s ‘wonder drugs’ that have, since the discovery of the antibacterial powers of <em>Penicillium</em> mould by Sir Alexander Fleming, transformed the potential and delivery of healthcare across the globe.
-
Diagnostic tests to prevent antibiotic resistance and treat resistant bacteria
Antibiotic resistance is a very important challenge for physicians, in particular in the therapy of multi-resistant micro-organisms. It is also key to differentiate viral from bacterial infections.
-
Can this new tech slow the progress of antibiotic resistance?
Decades of antibiotic overuse in healthcare and farming have led to a rapid rise in antibiotic resistance worldwide. Dr Natalie Whitfield, Director of Scientific and Medical Affairs at GenMark Diagnostics explains how new, rapid diagnostic technology can help fight this potential health crisis.
-
Outwitting drug resistance for better global population health
Drug-resistant organisms are evolving extremely quickly. So we are now faced with a challenge, in that people in hospitals and the community develop resistant infections and we don’t have effective drugs to treat them.
-
Sepsis or not? Molecular Gram, direct from blood in under four hours
Introducing a new class of product where all organisms in a whole blood sample can be put into a test, without which an early Gram result would not be possible.
-
Emerging requirements for quality control material
Times are changing in the clinical infectious diseases laboratory, particularly in the era of nucleic acid based testing.
-
Environmental impact of antibiotics production sparks global concerns
In an important milestone, at the G20 meeting in Hangzhou in September 2016, world leaders discussed the serious danger to public health, growth and global economic stability posed by antimicrobial resistance (AMR).
-
Tackling AMR: global solutions for a global challenge
Antibiotic resistance can affect anyone, of any age, in any country. It’s one of the biggest threats to global health, food security, and development today, and a barrier to achieving Sustainable Development Goal 3.